LAS VEGAS, NV – JANUARY 10: Kodak signage is displayed during CES 2018 at the Las Vegas Convention Center on January 10, 2018 in Las Vegas, Nevada. CES, the world’s largest annual consumer technology trade show, runs through January 12 and features about 3,900 exhibitors showing off their latest products and services to more than 170,000 attendees. (Photo by David Becker/Getty Images)

Eastman Kodak’s potentially lucrative deal to help the U.S. government make more generic drugs domestically is threatening to turn into a regulatory headache for the fallen photography giant.

Kodak’s depressed stock price surged last week before the company announced its plans to work with President Donald Trump’s administration in exchange for a $765 million loan. That prompted Senator Elizabeth Warren to send a Monday letter asking the U.S. Securities and Exchange Commission to investigate whether insider trading laws have been broken.

The SEC is now in the early stages of a probe, according to a report published Tuesday by the Wall Street Journal. The newspaper cited unidentified people it said were familiar with the matter.

The SEC declined to comment on the report. Kodak said Tuesday that the Rochester, New York, company intends to cooperate with any potential inquiries, without saying whether it has been contacted by the SEC.

The company’s stock soared on the July 28 news about the $765 million loan from the federal government to help Kodak make factory changes necessary to produce pharmaceutical ingredients in short supply in the U.S. Its shares rocketed from around $2 to as high as $60 before some of its former debt was converted into stock as part of a complex arrangement.

The conversion resulted in Kodak issuing nearly 30 million additional shares, undercutting the value of the stock already outstanding. Kodak’s stock closed at $14.40 after falling 3.6% in Tuesday’s trading.

Any investigation is likely to focus in an abrupt rally and trading frenzy in Kodak’s stock before the company and the Trump administration made their announcement. The rally may have been triggered by some of the news being shared online on Twitter and websites by at least two reporters in Rochester and two television stations before the official release of the information.

In its Tuesday statement, Kodak said it didn’t intend for the news to be shared by the media in advance.

Asked Tuesday at the White House if he had concerns about the Kodak deal, Trump told reporters: “Well, I don’t know. I wasn’t involved in the deal. The concept of the deal is good, but I’ll let you know.”

He added, “If there is any problem, we’ll let you know about it very quickly, but I wasn’t involved in it.”

Last week, Trump hailed the deal as a breakthrough in bringing more pharmaceutical manufacturing to the United States, and said Kodak has hired some “of the best people in the world” for the new venture.

Warren, a former Democratic Party presidential candidate from Massachusetts, also asked the SEC to look into whether Kodak board members were buying stock in the company while they were secretly negotiating the loan with the Trump administration.

After the news of the deal came out, Kodak also disclosed in regulatory filings that it had issued stock options to several executives on July 27 before its shares soared. Kodak CEO James Continenza was among the recipients.

Kodak said the stock option grants were approved by shareholders in May and issued July 27 to preserve the value Continenza had already earned before the dilution triggered by the conversion of old debt.

Although Kodak became world famous for its inroads in photography before digital technology decimated the market for film, it also has a lesser-known pharmaceutical division. The government loan agreement, which hasn’t been finalized, is supposed to be used to help expand and renovate existing plants in Rochester and St. Paul, Minnesota.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Long Bailey says she doesn’t regret working on hospital PFIs

Rebecca Long-Bailey says she has no regrets about working on PFI contracts before she became an MP, after criticism that she helped “privatise the NHS”. The Labour leadership contender defended her previous involvement as a solicitor, saying: “It’s one of…

Acting U.S. Navy secretary resigns after ridiculing commander of coronavirus-hit ship

WASHINGTON (Reuters) – Acting Navy Secretary Thomas Modly resigned on Tuesday after he faced mounting backlash for firing and ridiculing the commander of a U.S. aircraft carrier who pleaded for help stemming a coronavirus outbreak onboard. U.S. Defense Secretary Mark…

Sanders says he wants to tax billionaires’ ‘obscene’ wealth earned during coronavirus pandemic

Reaction from Independent Women’s Forum senior policy analyst Kelsey Bolar. Sen. Bernie Sanders said he will introduce legislation that taxes the “obscene wealth gains” of billionaires during the coronavirus pandemic. Sanders, a self-avowed democratic socialist, wrote in a series of tweets…

Cuomo says New York City violence dissipated Tuesday night

New York Governor Andrew Cuomo gave an update Wednesday on the state’s response to the coronavirus pandemic and protests over George Floyd’s death. He spoke after New York City spent its second night under curfew.  Cuomo noted that New York is on its 95th…